Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Generic drugFirst approved 1996

Captopril

Medicare prescription drug cost, prescriptions and prescribers, 2024

$5.1M

Medicare cost, 2024

Medicare drug plans spent $5.1 million on Captopril in 2024, for 70,927 prescriptions and refills filled by 17,054 patients. Spending fell 44% from 2023 to 2024. California accounts for the most spending ($696,241, 14% of the total).

Medicare cost, 2024

$5.1M

-44.4% from 2023

Prescriptions

71K

$71.31 per claim

Patients

17K

17,735 prescribers

Total spending, 2024

$5.1M

$296.54 per patient

Questions and answers

How much does Medicare spend on Captopril?

Medicare prescription drug plans paid $5.1M for Captopril in 2024, for 70,927 prescriptions and refills to 17,054 patients (down 44.4% from 2023). The average cost per claim was $71.31.

Which state spends the most on Captopril?

California had the highest Medicare cost for Captopril in 2024: $696K for 11,485 claims, followed by Puerto Rico ($396K).

Who prescribes Captopril the most?

Vlad Nusinovich, internal medicine in West Hollywood, CA, had the highest Medicare cost for Captopril in 2024: 779 claims costing $18K.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Captopril was $5.1M in 2024, after a high of $14.4M in 2020.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Captopril, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Vlad Nusinovich West Hollywood, CAInternal Medicine77983$18K
Jane Y Kauffman West Hollywood, CACardiology58774$15K
Mark Barats West Hollywood, CANephrology25530$13K
Thomas L Slokan Beaver Falls, PAFamily Practice35Under 11$8,065
Jose A Padilla San Juan, PRCardiology29Under 11$6,600
Rayleen Villanueva-Rumpf San Antonio, TXInternal Medicine29Under 11$5,432
Jose F de Leon Vega Baja, PRInternal Medicine27Under 11$5,123
Arkady Stern Los Angeles, CAFamily Practice13216$5,026
Eleonora Fedonenko Los Angeles, CAInternal Medicine14314$4,549
Bryson L Wandling San Luis, AZPhysician Assistant28Under 11$4,540
Anton Furman Levittown, PAFamily Practice37Under 11$4,086
Sherif Y Labatia Lakewood, CAFamily Practice35Under 11$4,037
Ana K Garcia Oklahoma City, OKNurse Practitioner12Under 11$3,868
Andrea Woodcock Bowling Green, KYNurse Practitioner25Under 11$3,794
Armine Nazaryan Glendale, CAGeneral Practice10411$3,710
Pavel Goykhman West Hollywood, CAInterventional Cardiology9827$3,554
Abdul H Sofi Perry, FLInternal Medicine12Under 11$3,545
Bhanuprasad L Patel Chicago, ILInternal Medicine12Under 11$3,374
Jorge J Ballester Echegaray Lares, PRGeneral Practice29Under 11$3,322
Michael D Sheehan Richmond, VAFamily Practice24Under 11$3,248
Jeffrey Rothstein Hollywood, FLFamily Practice15Under 11$3,182
Jose Sanchez-Lopez Humacao, PRGeneral Practice17Under 11$3,145
Ganesh Asaithambi Beckley, WVCardiology3013$3,072
Francisco Ordaz-Chavez Yuma, AZFamily Practice16Under 11$3,050
1679533616 Family Practice4112$3,038

Prescriber data by year

YearPrescribersClaimsPatientsCost
202220,66085,73120,282$10.6M
202318,99877,02118,374$9.1M
202417,73570,92717,054$5.1M

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Camber Pharmace26,508$1.8M
Ajanta Pharma LAJANTPHARM.NS logoAJANTPHARM.NS19,815$1.4M
Amici Pharmaceu11,456$885K
West-Ward/HikmaHIK.L logoHIK.L9,898$678K
Solco Healthcar2,764$220K
SandozSDZ.SW logoSDZ.SW475$33K
Major Pharmaceu12$715

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
78
RxNorm concept IDs
308962, 308963, 308964, 317173
Application numbers
ANDA074477, ANDA074505, ANDA074677, ANDA074737, ANDA212809

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube